ZEISS has brought fiscal year 2012/13 to a successful conclusion with an all-time high in revenue. The company put in a good performance in some sectors despite a partly difficult economic environment and generated revenue totaling EUR 4.190 billion (prior year: EUR 4.163 billion) and earni ... more
Carl Zeiss Licences Digital Pathology from Olympus
17-07-2012: Carl Zeiss Microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.
"The handling of digital data has become a major driver of the development of modern microscopy,” said Dr. Bernhard Ohnesorge, Member of the Board and General Manager BioSciences Division of Carl Zeiss Microscopy. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”
“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” said Brad Burklow, Executive Director Business Development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”
The companies are not making specific terms and conditions of the agreement public.
The start of calendar year 2014 will see some changes to the Executive Board of Carl Zeiss AG headed by President and CEO Dr. Michael Kaschke. The enlargement of the Executive Board and the reallocation of responsibilities are aimed at driving forward the consistent positioning of ZEISS as ... more
Facing a slight downturn in the overall market, Medical technology provider Carl Zeiss Meditec AG raised its revenue by 2.9 percent to EUR 649 million (previous year: EUR 630.8 million) in the first nine months of financial year 2011/2012. In the first nine months of the current financial y ... more
Carl Zeiss MicroImaging GmbH is a 100% subsidiary of Carl Zeiss AG. The leading manufacturer of microscope systems offers total solutions for biomedical research, the healthcare sector and high-tech industries. The product line spans a broad spectrum from light microscopes and systems for l ... more
Carl Zeiss Microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal c ... more
The National Research Council Canada (NRC) recently helped Olympus to design and commercialize a CARS (Coherent Anti-stokes Raman Scattering) microscope. The new Olympus microscope is based on a femtosecond non-linear optical process called CARS, which stands for Coherent Anti-Stokes Raman ... more
Olympus Microscopy has partnered with the Nature Publishing Group to present the Neurotechniques Collection. This compilation of articles will draw together some of the groundbreaking research that has recently been published in Nature Reviews Neuroscience and Nature Methods. Sponsored by O ... more
Olympus is one of the world’s leading manufacturers of professional opto-digital products in medicine, science and industry. The company covers a broad-ranging business segment, including microscope systems for life and materials science as well as powerful analytical systems. more
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2Almost as sensitive as a dog's nose
- 3Three-dimensional model of bacterium
- 4Raman keeps lipstick evidence in the bag
- 5Do you want to know how much caffeine is in your drink?
- 6Breakthrough in DNA editing technology
- 73D IR images now in full color
- 8PIAB announces new Chief Executive Officer
- 9‘Forensic fingers’ for crime scene investigation
- 10Raman pixel by pixel
- Analytik Jena gains major contract in China
- Polyplus-transfection and the National Institute of Health sign a research l ...
- Altmann Analytik acquires lab supplier Dinkelberg analytics
- analytica 2014: New special exhibit for occupational health and safety
- CyBio AG delivers major contract to Boehringer Ingelheim